Rising Chronic Kidney Disease Prevalence Drives Growth In Related Health Complications Driver: Leading Transformation in the Calciphylaxis Market in 2025

What combination of drivers is leading to accelerated growth in the calciphylaxis market?
The growing prevalence of obesity is also expected to drive the expansion of the calciphylaxis market. Obesity is characterized by excessive body fat accumulation, which increases the risk of numerous health problems, such as heart disease, diabetes, and hypertension. The rise in obesity is attributed to sedentary lifestyles, high-calorie diets, genetic factors, and limited access to healthy food. Obesity increases the risk of calciphylaxis due to metabolic dysfunction, chronic inflammation, and vascular calcification, which exacerbate calcium-phosphate imbalances and endothelial damage, particularly in individuals with CKD. In September 2023, the Centers for Disease Control and Prevention reported that in 2022, 22 states in the U.S. had an adult obesity rate of 35% or higher, up from 19 states in 2021. As such, the growing prevalence of obesity is contributing to the growth of the calciphylaxis market.

Get Your Calciphylaxis Market Report Here:
https://www.thebusinessresearchcompany.com/report/calciphylaxis-global-market-report

What is the projected compound annual growth rate (CAGR) of the calciphylaxis market from 2025 to 2034, and what factors influence it?
The calciphylaxis market has expanded rapidly, with projections to grow from $3.22 billion in 2024 to $3.55 billion in 2025, achieving a CAGR of 10.0%. Key growth factors include the increasing prevalence of chronic kidney disease, rising awareness of rare diseases, greater government support for rare disease research, a favorable regulatory landscape, and higher healthcare expenditure.

The calciphylaxis market is poised for robust growth, expanding to $5.13 billion by 2029 at a CAGR of 9.7%. Key growth drivers include an aging global population, emerging therapeutic innovations, expanded dialysis access in developing regions, increased investment in rare disease drug development, and a rising incidence of end-stage renal disease. Major trends shaping this market include improvements in dialysis and renal care, advancements in treatments for mineral and bone disorders, increased use of personalized medicine, progress in biotechnology, ongoing therapeutic advancements, and evolving healthcare policies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21124&type=smp

How are the latest trends influencing the growth of the calciphylaxis market?
Major companies in the calciphylaxis market are focusing on developing innovative therapies like enzyme replacement therapy (ERT) to improve treatment outcomes and reduce the severity of the condition. ERT replaces missing or deficient enzymes in the body and is typically used for rare genetic disorders. For example, in October 2024, Inozyme Pharma Inc., a U.S.-based biopharmaceutical company, announced positive interim results from its Phase 1 SEAPORT 1 trial of INZ-701 in end-stage kidney disease (ESKD) patients. The trial showed that INZ-701 could restore enzyme activity, helping to prevent abnormal mineralization, which is key to treating conditions like calciphylaxis caused by ENPP1 and ABCC6 deficiencies.

What are the major segments of the calciphylaxis market and their role in driving growth?
The calciphylaxis market covered in this report is segmented -

1) By Type: Non-Uremic Calciphylaxis, Ulcers And Wounds, Debridement Of Wounds
2) By Treatment: Drug Therapy, Hyperbaric Calciphylaxis Therapy
3) By Diagnosis: Deep Skin Biopsies, Blood Tests, Imaging
4) By End-Use: Hospital And Clinics, Homecare, Ambulatory Centers

Subsegments:
1) By Non-Uremic Calciphylaxis: Vascular Calcification, Soft Tissue Calcification, Cutaneous Manifestations
2) By Ulcers and Wounds: Skin Ulcers, Ischemic Wounds, Necrotic Ulcers, Pressure Ulcers
3) By Debridement Of Wounds: Surgical Debridement, Enzymatic Debridement, Autolytic Debridement, Mechanical Debridement, Biological Debridement

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21124

Which regions are key players in the growth of the calciphylaxis market?
North America was the largest region in the calciphylaxis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the calciphylaxis market?
Major companies operating in the calciphylaxis market are Baxter International Inc., Opko Health Inc., Hope Pharmaceuticals Ltd

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21124&type=smp

What Is Covered In The Calciphylaxis Global Market Report?

•Market Size Forecast: Examine the calciphylaxis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the calciphylaxis market for a structured understanding.
•Key Players Overview: Analyze major players in the calciphylaxis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the calciphylaxis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the calciphylaxis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the calciphylaxis market.
•Industry Challenges: Identify potential risks and obstacles affecting the calciphylaxis market.
•Competitive Landscape: Review strategic developments in the calciphylaxis market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.